Cover Image

HARDBACK
$52.95



View/Hide Left Panel

Table 4–2 Vaccine X-1: Mild/Moderate Illness with Deaths, Uniform Ages (cases: 100,000/year)

Deaths (from acute infection)

1%

 

Morbidity scenarios

Distribution of Cases

Duration

HUI

Health Care Costs

Mild

50%

2 weeks

0.90

1 MD visit=$50

Moderate

50%

2 weeks

0.70

1 MD visit=$50

Severea

0%

4 weeks

0.40

Brief hospitalization=$5,000

3 MD visits=$150

Permanent impairmenta

0%

Remaining lifetime

 

Brief hospitalization=$5,000

ICU hospitalization=$4,500

Characteristics of Vaccine Use and Development

Target population for vaccination

4 million infants

Cost of vaccine per dose

$50

Doses required

3

Vaccine effectiveness

75%

Utilization of vaccine

90%

Time to adoption at anticipated utilization

5 years

Cost for vaccine development

$240 million

Time for vaccine development

7 years

Discount Rates (r)

 

Health benefits

3%

Costs

3%



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement